{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:27:58Z","timestamp":1783056478640,"version":"3.54.6"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T00:00:00Z","timestamp":1598659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T00:00:00Z","timestamp":1598659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s11864-020-00784-2","type":"journal-article","created":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T18:06:31Z","timestamp":1598724391000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Surgical Principles in the Management of Small Bowel Neuroendocrine Tumors"],"prefix":"10.1007","volume":"21","author":[{"given":"Alexandra","family":"Gangi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Anaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,29]]},"reference":[{"issue":"18","key":"784_CR1","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","volume":"26","author":"JC Yao","year":"2008","unstructured":"Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, et al. One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26(18):3063\u201372. https:\/\/doi.org\/10.1200\/JCO.2007.15.4377.","journal-title":"J Clin Oncol."},{"key":"784_CR2","doi-asserted-by":"publisher","unstructured":"\u2022 Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3(10):1335\u201342. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0589 A retrospective, population-based study (N\u00a0=\u200964,971) using SEER data was conducted to determine whether epidemiology of NET changed over time from 1973 to 2012.","DOI":"10.1001\/jamaoncol.2017.0589"},{"key":"784_CR3","unstructured":"\u2022 International Agency for Research on Cancer (IARC). WHO classification of tumours of endocrine organs 4th ed. Medicine (Book 10). World Health Organization. 2017; This authoritative, concise reference book provides an international standard for oncologists\/pathologists and will serve as an indispensable guide for use in the design of SB NET-related studies evaluating response to therapy and clinical outcome."},{"issue":"2","key":"784_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.soc.2019.11.006","volume":"29","author":"AT Scott","year":"2020","unstructured":"\u2022 Scott AT, Howe JR. Management of small bowel neuroendocrine tumors. Surg Oncol Clin N Am. 2020;29(2):223\u201341. https:\/\/doi.org\/10.1016\/j.soc.2019.11.006 A recent review paper that summarizes surgical managment principles in SB NET.","journal-title":"Surg Oncol Clin N Am"},{"issue":"1","key":"784_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/SLA.0b013e31818e4641","volume":"249","author":"KY Bilimoria","year":"2009","unstructured":"Bilimoria KY, Bentrem DJ, Wayne JD, Ko CY, Bennett CL, Talamonti MS. Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20\u00a0years. Ann Surg. 2009;249(1):63\u201371. https:\/\/doi.org\/10.1097\/SLA.0b013e31818e4641.","journal-title":"Ann Surg."},{"issue":"3","key":"784_CR6","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/jnci\/djx174","volume":"110","author":"M Cives","year":"2018","unstructured":"Cives M, Anaya DA, Soares H, Coppola D, Strosberg J. Analysis of postoperative recurrence in stage I-III midgut neuroendocrine tumors. J Natl Cancer Inst. 2018;110(3):282\u20139. https:\/\/doi.org\/10.1093\/jnci\/djx174.","journal-title":"J Natl Cancer Inst."},{"issue":"7","key":"784_CR7","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1245\/s10434-018-6511-9","volume":"25","author":"L Chen","year":"2018","unstructured":"Chen L, Song Y, Zhang Y, Chen M, Chen J. Exploration of the exact prognostic significance of lymphatic metastasis in jejunoileal neuroendocrine tumors. Ann Surg Oncol. 2018;25(7):2067\u201374. https:\/\/doi.org\/10.1245\/s10434-018-6511-9.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"784_CR8","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1001\/jamasurg.2018.3865","volume":"154","author":"MY Zaidi","year":"2019","unstructured":"Zaidi MY, Lopez-Aguiar AG, Dillhoff M, Beal E, Poultsides G, Makris E, et al. Prognostic role of lymph node positivity and number of lymph nodes needed for accurately staging small-bowel neuroendocrine tumors. JAMA Surg. 2019;154(2):134\u201340. https:\/\/doi.org\/10.1001\/jamasurg.2018.3865.","journal-title":"JAMA Surg."},{"issue":"6","key":"784_CR9","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/MPA.0000000000000846","volume":"46","author":"JR Howe","year":"2017","unstructured":"\u2022\u2022 Howe JR, Cardona K, Fraker DL, Kebebew E, Untch BR, Wang YZ, et al. The surgical management of small bowel neuroendocrine tumors: consensus guidelines of the North American Neuroendocrine Tumor Society. Pancreas. 2017;46(6):715\u201331. https:\/\/doi.org\/10.1097\/MPA.0000000000000846 This manuscript is the result of the North American Neuroendocrine Tumor Society (NANETS) consensus conference on the surgical management of SB NET. The group of experts was assembled to review and discuss the available literature and patterns of practice pertaining to specific management issues. This paper summarizes the important elements from available studies and the recommendations for questions regarding the management of SB NET patients.","journal-title":"Pancreas"},{"issue":"6","key":"784_CR10","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1097\/MPA.0000000000000850","volume":"46","author":"JR Strosberg","year":"2017","unstructured":"Strosberg JR, Halfdanarson TR, Bellizzi AM, Chan JA, Dillon JS, Heaney AP, et al. The North American Neuroendocrine Tumor Society consensus guidelines for surveillance and medical management of midgut neuroendocrine tumors. Pancreas. 2017;46(6):707\u201314. https:\/\/doi.org\/10.1097\/MPA.0000000000000850.","journal-title":"Pancreas."},{"issue":"1","key":"784_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.hoc.2015.09.001","volume":"30","author":"HA Farley","year":"2016","unstructured":"\u2022 Farley HA, Pommier RF. Surgical treatment of small bowel neuroendocrine tumors. Hematology\/Oncology Clinics. 2016;30(1):49\u201361. https:\/\/doi.org\/10.1016\/j.hoc.2015.09.001 A review article summarizing surgical management of SB NET.","journal-title":"Hematology\/Oncology Clinics"},{"key":"784_CR12","volume-title":"Neuroendocrine tumors","author":"DA Anaya","year":"2019","unstructured":"Anaya DA, Fleming JB, Powers BD. Neuroendocrine tumors. Hochwald SC, W.G., editor. Complex general surgical oncology case-based reviews. Decker: In; 2019."},{"issue":"2","key":"784_CR13","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/jso.24825","volume":"117","author":"N Manguso","year":"2018","unstructured":"Manguso N, Gangi A, Johnson J, Harit A, Nissen N, Jamil L, et al. The role of pre-operative imaging and double balloon enteroscopy in the surgical management of small bowel neuroendocrine tumors: is it necessary? J Surg Oncol. 2018;117(2):207\u201312. https:\/\/doi.org\/10.1002\/jso.24825.","journal-title":"J Surg Oncol."},{"key":"784_CR14","unstructured":"National Comprehensive Cancer Network. Neuroendocrine and adrenal tumors (Version 1.2019). 2019."},{"key":"784_CR15","doi-asserted-by":"publisher","unstructured":"Eriksson J, Norlen O, Ogren M, Garmo H, Ihre-Lundgren C, Hellman P. Primary small intestinal neuroendocrine tumors are highly prevalent and often multiple before metastatic disease develops. Scand J Surg. 2019;1457496919874484. https:\/\/doi.org\/10.1177\/1457496919874484.","DOI":"10.1177\/1457496919874484"},{"issue":"2","key":"784_CR16","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11605-017-3586-8","volume":"22","author":"A Gangi","year":"2018","unstructured":"Gangi A, Siegel E, Barmparas G, Lo S, Jamil LH, Hendifar A, et al. Multifocality in small bowel neuroendocrine tumors. J Gastrointest Surg. 2018;22(2):303\u20139. https:\/\/doi.org\/10.1007\/s11605-017-3586-8.","journal-title":"J Gastrointest Surg."},{"issue":"7","key":"784_CR17","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1007\/s00268-013-1918-8","volume":"37","author":"CS Landry","year":"2013","unstructured":"Landry CS, Lin HY, Phan A, Charnsangavej C, Abdalla EK, Aloia T, et al. Resection of at-risk mesenteric lymph nodes is associated with improved survival in patients with small bowel neuroendocrine tumors. World Journal of Surgery. 2013;37(7):1695\u2013700. https:\/\/doi.org\/10.1007\/s00268-013-1918-8.","journal-title":"World Journal of Surgery."},{"issue":"8","key":"784_CR18","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1002\/jso.25727","volume":"120","author":"Y Kasai","year":"2019","unstructured":"Kasai Y, Mahuron K, Hirose K, Corvera CU, Kim GE, Hope TA, et al. Prognostic impact of a large mesenteric mass >\u20092\u00a0cm in ileal neuroendocrine tumors. J Surg Oncol. 2019;120(8):1311\u20137. https:\/\/doi.org\/10.1002\/jso.25727.","journal-title":"J Surg Oncol."},{"issue":"11","key":"784_CR19","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1007\/s002680010232","volume":"24","author":"U Ohrvall","year":"2000","unstructured":"Ohrvall U, Eriksson B, Juhlin C, Karacagil S, Rastad J, Hellman P, et al. Method for dissection of mesenteric metastases in mid-gut carcinoid tumors. World Journal of Surgery. 2000;24(11):1402\u20138. https:\/\/doi.org\/10.1007\/s002680010232.","journal-title":"World Journal of Surgery."},{"issue":"5","key":"784_CR20","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.amjsurg.2011.12.010","volume":"203","author":"KP Massimino","year":"2012","unstructured":"Massimino KP, Han E, Pommier SJ, Pommier RF. Laparoscopic surgical exploration is an effective strategy for locating occult primary neuroendocrine tumors. American Journal of Surgery. 2012;203(5):628\u201331. https:\/\/doi.org\/10.1016\/j.amjsurg.2011.12.010.","journal-title":"American Journal of Surgery."},{"issue":"5","key":"784_CR21","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1007\/s00464-013-3381-x","volume":"28","author":"MN Figueiredo","year":"2014","unstructured":"Figueiredo MN, Maggiori L, Gaujoux S, Couvelard A, Guedj N, Ruszniewski P, et al. Surgery for small-bowel neuroendocrine tumors: is there any benefit of the laparoscopic approach? Surg Endosc. 2014;28(5):1720\u20136. https:\/\/doi.org\/10.1007\/s00464-013-3381-x.","journal-title":"Surg Endosc."},{"issue":"6","key":"784_CR22","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1097\/SLA.0b013e31818730f0","volume":"248","author":"MH Katz","year":"2008","unstructured":"Katz MH, Fleming JB, Pisters PW, Lee JE, Evans DB. Anatomy of the superior mesenteric vein with special reference to the surgical management of first-order branch involvement at pancreaticoduodenectomy. Ann Surg. 2008;248(6):1098\u2013102. https:\/\/doi.org\/10.1097\/SLA.0b013e31818730f0.","journal-title":"Ann Surg."},{"issue":"9","key":"784_CR23","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1007\/s11605-019-04232-x","volume":"23","author":"JK Horwitz","year":"2019","unstructured":"Horwitz JK, Marin ML, Warner RRP, Lookstein RA, Divino CM. EndoVascular Occlusion and Tumor Excision (EVOTE): a hybrid approach to small-bowel neuroendocrine tumors with mesenteric metastases. J Gastrointest Surg. 2019;23(9):1911\u20136. https:\/\/doi.org\/10.1007\/s11605-019-04232-x.","journal-title":"J Gastrointest Surg."},{"issue":"Suppl 3","key":"784_CR24","doi-asserted-by":"publisher","first-page":"S742","DOI":"10.1245\/s10434-015-4620-2","volume":"22","author":"A Pasquer","year":"2015","unstructured":"Pasquer A, Walter T, Hervieu V, Forestier J, Scoazec JY, Lombard-Bohas C, et al. Surgical management of small bowel neuroendocrine tumors: specific requirements and their impact on staging and prognosis. Ann Surg Oncol. 2015;22(Suppl 3):S742\u20139. https:\/\/doi.org\/10.1245\/s10434-015-4620-2.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"784_CR25","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/MPA.0000000000001005","volume":"47","author":"W Chi","year":"2018","unstructured":"Chi W, Warner RRP, Chan DL, Singh S, Segelov E, Strosberg J, et al. Long-term outcomes of gastroenteropancreatic neuroendocrine tumors. Pancreas. 2018;47(3):321\u20135. https:\/\/doi.org\/10.1097\/MPA.0000000000001005.","journal-title":"Pancreas."},{"issue":"5","key":"784_CR26","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/bjs5.76","volume":"2","author":"J Eriksson","year":"2018","unstructured":"Eriksson J, Garmo JEH, Ihre-Lundgren C, Hellman P. Prognostic factors for death after surgery for small intestinal neuroendocrine tumours. BJS Open. 2018;2(5):345\u201352. https:\/\/doi.org\/10.1002\/bjs5.76.","journal-title":"BJS Open."},{"issue":"5","key":"784_CR27","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1245\/s10434-016-5703-4","volume":"24","author":"J Eriksson","year":"2017","unstructured":"Eriksson J, Garmo H, Hellman P, Ihre-Lundgren C. The influence of preoperative symptoms on the death of patients with small intestinal neuroendocrine tumors. Ann Surg Oncol. 2017;24(5):1214\u201320. https:\/\/doi.org\/10.1245\/s10434-016-5703-4.","journal-title":"Ann Surg Oncol."},{"issue":"10","key":"784_CR28","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1177\/000313481808401006","volume":"84","author":"N Manguso","year":"2018","unstructured":"Manguso N, Gangi A, Nissen N, Harit A, Siegel E, Hendifar A, et al. Long-term outcomes after elective versus emergency surgery for small bowel neuroendocrine tumors. Am Surg. 2018;84(10):1570\u20134.","journal-title":"Am Surg."},{"issue":"4","key":"784_CR29","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1159\/000486097","volume":"106","author":"FM Laskaratos","year":"2018","unstructured":"Laskaratos FM, Diamantopoulos L, Walker M, Walton H, Khalifa M, El-Khouly F, et al. Prognostic factors for survival among patients with small bowel neuroendocrine tumours associated with mesenteric desmoplasia. Neuroendocrinology. 2018;106(4):366\u201380. https:\/\/doi.org\/10.1159\/000486097.","journal-title":"Neuroendocrinology."},{"issue":"6","key":"784_CR30","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1097\/01.sla.0000164073.08093.5d","volume":"241","author":"JP Boudreaux","year":"2005","unstructured":"Boudreaux JP, Putty B, Frey DJ, Woltering E, Anthony L, Daly I, et al. Surgical treatment of advanced-stage carcinoid tumors: lessons learned. Ann Surg. 2005;241(6):839\u201345; discussion 45\u20136. https:\/\/doi.org\/10.1097\/01.sla.0000164073.08093.5d.","journal-title":"Ann Surg."},{"issue":"8","key":"784_CR31","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00268-002-6630-z","volume":"26","author":"P Hellman","year":"2002","unstructured":"Hellman P, Lundstrom T, Ohrvall U, Eriksson B, Skogseid B, Oberg K, et al. Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases. World Journal of Surgery. 2002;26(8):991\u20137. https:\/\/doi.org\/10.1007\/s00268-002-6630-z.","journal-title":"World Journal of Surgery."},{"issue":"12","key":"784_CR32","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1177\/000313481908501225","volume":"85","author":"EA Armstrong","year":"2019","unstructured":"Armstrong EA, Beal EW, Lopez-Aguiar AG, Poultsides G, Cannon JG, Rocha F, et al. Evaluating the ACS-NSQIP Risk Calculator in primary GI neuroendocrine tumor: results from the United States Neuroendocrine Tumor Study Group. Am Surg. 2019;85(12):1334\u201340.","journal-title":"Am Surg."},{"issue":"3","key":"784_CR33","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1677\/ERC-09-0042","volume":"16","author":"A Ahmed","year":"2009","unstructured":"Ahmed A, Turner G, King B, Jones L, Culliford D, McCance D, et al. Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study. Endocr Relat Cancer. 2009;16(3):885\u201394. https:\/\/doi.org\/10.1677\/ERC-09-0042.","journal-title":"Endocr Relat Cancer."},{"issue":"6","key":"784_CR34","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.surg.2014.08.009","volume":"156","author":"AN Graff-Baker","year":"2014","unstructured":"Graff-Baker AN, Sauer DA, Pommier SJ, Pommier RF. Expanded criteria for carcinoid liver debulking: maintaining survival and increasing the number of eligible patients. Surgery. 2014;156(6):1369\u201376; discussion 76\u20137. https:\/\/doi.org\/10.1016\/j.surg.2014.08.009.","journal-title":"Surgery."},{"issue":"12","key":"784_CR35","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1245\/s10434-010-1154-5","volume":"17","author":"SC Mayo","year":"2010","unstructured":"Mayo SC, de Jong MC, Pulitano C, Clary BM, Reddy SK, Gamblin TC, et al. Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis. Ann Surg Oncol. 2010;17(12):3129\u201336. https:\/\/doi.org\/10.1245\/s10434-010-1154-5.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"784_CR36","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1477-2574.2010.00198.x","volume":"12","author":"ES Glazer","year":"2010","unstructured":"Glazer ES, Tseng JF, Al-Refaie W, Solorzano CC, Liu P, Willborn KA, et al. Long-term survival after surgical management of neuroendocrine hepatic metastases. HPB (Oxford). 2010;12(6):427\u201333. https:\/\/doi.org\/10.1111\/j.1477-2574.2010.00198.x.","journal-title":"HPB (Oxford)."},{"issue":"11","key":"784_CR37","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1002\/bjs.8842","volume":"99","author":"G Capurso","year":"2012","unstructured":"Capurso G, Rinzivillo M, Bettini R, Boninsegna L, Delle Fave G, Falconi M. Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases. The British Journal of Surgery. 2012;99(11):1480\u20136. https:\/\/doi.org\/10.1002\/bjs.8842.","journal-title":"The British Journal of Surgery."},{"issue":"10","key":"784_CR38","doi-asserted-by":"publisher","first-page":"17396","DOI":"10.18632\/oncotarget.14156","volume":"8","author":"J Guo","year":"2017","unstructured":"Guo J, Zhang Q, Bi X, Zhou J, Li Z, Huang Z, et al. Systematic review of resecting primary tumor in MNETs patients with unresectable liver metastases. Oncotarget. 2017;8(10):17396\u2013405. https:\/\/doi.org\/10.18632\/oncotarget.14156.","journal-title":"Oncotarget"},{"issue":"5","key":"784_CR39","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1007\/s11605-018-04094-9","volume":"23","author":"DI Tsilimigras","year":"2019","unstructured":"Tsilimigras DI, Ntanasis-Stathopoulos I, Kostakis ID, Moris D, Schizas D, Cloyd JM, et al. Is resection of primary midgut neuroendocrine tumors in patients with unresectable metastatic liver disease justified? A systematic review and meta-analysis. J Gastrointest Surg. 2019;23(5):1044\u201354. https:\/\/doi.org\/10.1007\/s11605-018-04094-9.","journal-title":"J Gastrointest Surg."},{"issue":"2","key":"784_CR40","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1001\/jamaoncol.2017.3326","volume":"4","author":"K Daskalakis","year":"2018","unstructured":"Daskalakis K, Karakatsanis A, Hessman O, Stuart HC, Welin S, Tiensuu Janson E, et al. Association of a prophylactic surgical approach to stage IV small intestinal neuroendocrine tumors with survival. JAMA Oncol. 2018;4(2):183\u20139. https:\/\/doi.org\/10.1001\/jamaoncol.2017.3326.","journal-title":"JAMA Oncol."}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-020-00784-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11864-020-00784-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-020-00784-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T23:28:03Z","timestamp":1630193283000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11864-020-00784-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,29]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["784"],"URL":"https:\/\/doi.org\/10.1007\/s11864-020-00784-2","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,29]]},"assertion":[{"value":"29 August 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Alexandra Gangi declares that she has no conflict of interest. Daniel A. Anaya declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"88"}}